Literature DB >> 8850477

Severe restriction in jaw movement after routine injection of local anesthetic in patients who have fibrodysplasia ossificans progressiva.

W Luchetti1, R B Cohen, G V Hahn, D M Rocke, M Helpin, M Zasloff, F S Kaplan.   

Abstract

OBJECTIVE: To determine the relationship of dental procedures to immediate ossification and ankylosis of the jaw in patients who have fibrodysplasia ossificans progressiva. STUDY
DESIGN: A mail survey was conducted of the 60 patient-members of the International Fibrodysplasia Ossificans Progressiva Association. All 41 patients (18 males, 23 females) who responded were examined. Instantaneous exact hazard rates for ossification of the jaw were calculated by the Weibull model.
RESULTS: Thirty-six patients had dental procedures performed. Twenty-one (58%) patients had received an injection of local anesthetic. Five (24%) patients had an immediate flare-up of fibrodysplasia ossificans progressiva with ossification and permanent ankylosis of the jaw (expected occurrence, 0.031; p < 0.0001). None of the 12 patients who had comparable dental work without injections developed heterotopic ossification (expected occurrence, 0.019; not significant).
CONCLUSION: Injections of local anesthetic during dental procedures pose serious and immediate risk for inciting heterotopic ossification and ankylosis of the jaw in patients who have fibrodysplasia ossificans progressiva and should be assiduously avoided.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8850477     DOI: 10.1016/s1079-2104(96)80141-7

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  26 in total

1.  Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

Authors:  G Feldman; M Li; S Martin; M Urbanek; J A Urtizberea; M Fardeau; M LeMerrer; J M Connor; J Triffitt; R Smith; M Muenke; F S Kaplan; E M Shore
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

2.  Fibrodysplasia ossificans progressiva: a human genetic disorder of extraskeletal bone formation, or--how does one tissue become another?

Authors:  Eileen M Shore
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jan-Feb       Impact factor: 5.814

3.  Chin-on-chest deformity in patients with fibrodysplasia ossificans progressiva. A case series.

Authors:  Ryan E Moore; John P Dormans; Denis S Drummond; Eileen M Shore; Frederick S Kaplan; Joshua D Auerbach
Journal:  J Bone Joint Surg Am       Date:  2009-06       Impact factor: 5.284

Review 4.  A systematic review of the use of local analgesia in medically compromised children and adolescents.

Authors:  A Dougall; M Hayes; B Daly
Journal:  Eur Arch Paediatr Dent       Date:  2017-10-05

Review 5.  Fibrodysplasia ossificans progressiva: Basic understanding and experimental models.

Authors:  Zijuan Qi; Jing Luan; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2017-11

6.  Early diagnosis of fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Meiqi Xu; David L Glaser; Felicity Collins; Michael Connor; Joseph Kitterman; David Sillence; Elaine Zackai; Vardit Ravitsky; Michael Zasloff; Arupa Ganguly; Eileen M Shore
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

7.  PET/CT of fibrodysplasia ossificans progressiva.

Authors:  Robert Kulwin; Larry A Binkovitz
Journal:  Pediatr Radiol       Date:  2009-05-15

8.  General anesthesia for dental procedures in patients with fibrodysplasia ossificans progressiva: a review of 42 cases in 30 patients.

Authors:  Elaine Kilmartin; Zvi Grunwald; Frederick S Kaplan; Burton L Nussbaum
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

9.  When one skeleton is enough: approaches and strategies for the treatment of fibrodysplasia ossificans progressiva (FOP).

Authors:  Frederick S Kaplan; Jay Groppe; Eileen M Shore
Journal:  Drug Discov Today Ther Strateg       Date:  2008

10.  Biological activity of a genetically modified BMP-2 variant with inhibitory activity.

Authors:  Uwe Klammert; Joachim Nickel; Kristian Würzler; Christoph Klingelhöffer; Walter Sebald; Alexander C Kübler; Tobias Reuther
Journal:  Head Face Med       Date:  2009-02-02       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.